Chih-Cheng Lai - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Chih-Cheng Lai - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2003	1
2004	1
2005	5
2006	4
2007	9
2008	12
2009	13
2010	29
2011	47
2012	37
2013	45
2014	36
2015	25
2016	21
2017	37
2018	32
2019	45
2020	54
2021	58
2022	62
2023	70
2024	17

567 results

Page of 57

Results by year

Page 1

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants.

Hsu CK, Hsu WH, Shiau BW, Tsai YW, Wu JY, Liu TH, Huang PY, Chuang MH, Lai CC. Hsu CK, et al. Among authors: lai cc. Expert Rev Anti Infect Ther. 2024 Apr 8:1-8. doi: 10.1080/14787210.2024.2339398. Online ahead of print. Expert Rev Anti Infect Ther. 2024. PMID: 38568820

Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease.

Chen CC, Huang CY, Wu JY, Liu MY, Chuang MH, Liu TH, Tsai YW, Hsu WH, Huang PY, Chen MH, Liu SY, Lee MC, Hung KC, Lai CC, Yang IN. Chen CC, et al. Among authors: lai cc. Expert Rev Anti Infect Ther. 2024 Mar 26:1-8. doi: 10.1080/14787210.2024.2334052. Online ahead of print. Expert Rev Anti Infect Ther. 2024. PMID: 38525673

The intervention of artificial intelligence to improve the weaning outcomes of patients with mechanical ventilation: Practical applications in the medical intensive care unit and the COVID-19 intensive care unit: A retrospective study.

Lin YH, Chang TC, Liu CF, Lai CC, Chen CM, Chou W. Lin YH, et al. Among authors: lai cc. Medicine (Baltimore). 2024 Mar 22;103(12):e37500. doi: 10.1097/MD.0000000000037500. Medicine (Baltimore). 2024. PMID: 38518051 Free PMC article.

Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and meta-analysis.

Lin CC, Wu JY, Huang PY, Sung HL, Tung YC, Lai CC, Wei YF, Fu PK. Lin CC, et al. Among authors: lai cc. Expert Rev Anti Infect Ther. 2024 Mar 5:1-11. doi: 10.1080/14787210.2024.2324940. Online ahead of print. Expert Rev Anti Infect Ther. 2024. PMID: 38441052 Review.

Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients.

Tey SF, Tsai YW, Wu JY, Liu TH, Chuang MH, Hsu WH, Huang PY, Lai CC, Hsu CK. Tey SF, et al. Among authors: lai cc. Front Public Health. 2024 Feb 16;12:1337646. doi: 10.3389/fpubh.2024.1337646. eCollection 2024. Front Public Health. 2024. PMID: 38435287 Free PMC article.

The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study.

Yang CC, Tsai YW, Wang SH, Wu JY, Liu TH, Hsu WH, Huang PY, Chuang MH, Sheu MJ, Lai CC. Yang CC, et al. Among authors: lai cc. Front Pharmacol. 2024 Feb 15;15:1321155. doi: 10.3389/fphar.2024.1321155. eCollection 2024. Front Pharmacol. 2024. PMID: 38425651 Free PMC article.

Evaluation of three brands of Mueller-Hinton media for broth microdilution method to determine the susceptibility of multidrug-resistant Gram-negative bacilli against eravacycline.

Hsu CK, Lai CC, Chen CC, Chen HJ, Tang HJ. Hsu CK, et al. Among authors: lai cc. Int J Antimicrob Agents. 2024 May;63(5):107117. doi: 10.1016/j.ijantimicag.2024.107117. Epub 2024 Feb 24. Int J Antimicrob Agents. 2024. PMID: 38408495 No abstract available.

Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014-21.

Wang JL, Lai CC, Tsai YW, Hsueh CC, Ko WC, Hsueh PR. Wang JL, et al. Among authors: lai cc. Int J Antimicrob Agents. 2024 Apr;63(4):107103. doi: 10.1016/j.ijantimicag.2024.107103. Epub 2024 Feb 6. Int J Antimicrob Agents. 2024. PMID: 38325725

High ceftazidime-avibactam resistance among carbapenem-resistant Enterobacter species: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014-2021.

Wang JL, Lai CC, Tsai YW, Ko WC, Hsueh PR. Wang JL, et al. Among authors: lai cc. Int J Antimicrob Agents. 2024 Apr;63(4):107105. doi: 10.1016/j.ijantimicag.2024.107105. Epub 2024 Feb 6. Int J Antimicrob Agents. 2024. PMID: 38325719

Clinical efficacy of N-acetylcysteine for COVID-19: A systematic review and meta-analysis of randomized controlled trials.

Liu TH, Wu JY, Huang PY, Tsai YW, Hsu WH, Chuang MH, Tang HJ, Lai CC. Liu TH, et al. Among authors: lai cc. Heliyon. 2024 Jan 26;10(3):e25179. doi: 10.1016/j.heliyon.2024.e25179. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38318025 Free PMC article.

567 results

Page of 57

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

567 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

567 results

Results by year